The classes of biologics with approved drugs for treatment of psoriatic arthritis include: Tumor necrosis factor (TNF)-alpha ...

The use of biologics in psoriasis and psoriatic arthritis management is not linked to the risk of cardiovascular or venous thromboembolic events.

The study grouped 32,098 patients with psoriasis or psoriatic arthritis (PsA) into their respective categories based on biologic treatment, which included TNFi (n = 20,314), IL-17i (n = 5,073), IL ...

Injectable drugs such as methotrexate and biologics may help clear up plaques and reduce inflammation. Biologics often help when other treatments haven’t worked to treat psoriasis. They’re ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

A new oral treatment for psoriatic arthritis ... inadequately controlled by disease-modifying anti-rheumatic drugs (DMARDs) and/or biologics. More than 75% of patients were previously treated ...

Treatment targets & strategies Remission, or at least minimal disease activity, should be the target of all treatment strategies in psoriatic arthritis. All musculoskeletal and cutaneous ...

Biologics are given by injection or infusion. There are several categories of these drugs: Acthar gel (repository ... for ...

Hispanic and non-White patients with psoriatic arthritis (PsA) had higher tender joint counts and greater disease severity, highlighting racial and ethnic disparities in PsA disease burden and ...

In recent years, there's been a revolution in Disease-Modifying Antirheumatic Drugs ... have a look at how biologics work to help correct it. ALLAN GIBOFSKY: In rheumatoid arthritis, a person's ...

We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...

A deeper understanding of the inflammatory processes driving psoriasis and psoriatic ... biologic therapies offer another approach to managing patients with moderate to severe disease. These ...